Month: November 2024

Precision for Medicine to Offer Spatial Biology Solutions Incorporating the PhenoCycler®-Fusion 2.0 System and the new Phenocode™ Discovery IO60 Panel from Akoya Biosciences

Breakthrough Spatial Biology Solutions Accelerate Immuno-Oncology (IO) Drug Discovery and Development BETHESDA, Md., Nov. 6, 2024 /PRNewswire/ -- Precision for...

Maple Leaf Green World Inc. Has Appointed Green Castle Environmental Ltd. as the Project Manager for Its Zero-Emission Affordable Housing Project in The Alberta Palliser Region

Calgary, Alberta--(Newsfile Corp. - November 6, 2024) - Maple Leaf Green World Inc. (CSE: MGW) (OTC Pink: MGWFF) ("Maple Leaf" or the...

Lisata Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update on Tuesday, November 12, 2024

BASKING RIDGE, N.J., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA), a clinical-stage pharmaceutical company developing innovative...

Sonnet BioTherapeutics Announces Issuance of U.S. Patent Covering a Variant IL-18 Incorporated into Two Novel Immunotherapeutic Drug Candidates

Both novel bifunctional (SON-1411) and monofunctional (SON-1400) fusion proteins exhibit wild-type binding to the IL-18 receptor (IL-18Rc), coupled with undetectable...

error: Content is protected !!